Maetzold’s presentation will take place during the AZAdvances Life Science Innovation Showcase on October 6Continue reading
Category Archives: AZBio News
UArizona Cancer Center Researchers Identify Mechanism for Slowing Cancer Growth
A newly discovered mechanism for controlling blood vessel growth in tumors points to possible strategies for developing new therapeutic interventions to overcome drug resistance.
Surveillance of Wastewater and Prevention Platform (SWAPP): A Case Study of Digital Public Health and SARS-CoV-2
InerOme, University of California San Diego, and Fry Laboratories published an article in the Journal of Precision Medicine, detailing a cloud based digital health Surveillance of Wastewater and Prevention Platform for COVID-19.
Humabiologics becomes ISO 13485 Certified and GMP Compliant Manufacturer
The ISO 13485:2016 registration positions Humabiologics among the first global providers of GMP (Good Manufacturing Practices) grade human-derived biomaterials to support and expedite the future development of human regenerative therapies and tissue models for drug discovery through clinically relevant high-quality products. Continue reading
HybridChart Partners with athenahealth’s Marketplace Program to Bring Workflow Efficiency Solution to Rounding Physicians
Scottsdale, AZ – September 23, 2021 – HybridChart, a leading solutions provider for charge capture and workflow management, announced a partnership with athenahealth, Inc. joining the company’s Marketplace program. As part of the athenahealth® Marketplace, the EVOLVE product by HybridChart is a newly integrated application now available to athenahealth’s growing network of healthcare providers.Continue reading
Nationwide study of 295,000 brain cancer patients examines differences due to age and sex
Study by TGen and collaborators documents different outcomes for males and females at various ages
PHOENIX, Ariz. — Sept. 22, 2021 — Findings from a national study by researchers at Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and external collaborators suggest that sex and age are crucial factors in the care and survival of patients with malignant brain tumors and other central nervous system (CNS) cancers.
Are Innovations in Chemistry Your Thing? Apply to Present in the Scorpion Pit
RMRM 2021 Scorpion Pit Competition
Tucson Marriott University Park, Tucson, Arizona
Thursday, October 21, 2021 5:00 – 7:00 PMContinue reading
Ivy Brain Tumor Center and SonALAsense Announce Positive Initial Results of the First-in-Human Phase 0/1 Clinical Trial of Non-Invasive Sonodynamic Therapy for Recurrent Glioblastoma
Trial provides proof of concept for this new metabolically targeted, rapidly acting technology platform for brain tumors and other lethal cancersContinue reading
BMSEED Awarded Grant to Develop the First Adaptable, 3-D Recording Technology for Brain Organoids
New 3D Microelectrode Arrays will Advance Organoid-Based Models for Neurological and Neurodegenerative DiseasesContinue reading
Here’s how the Arizona bioscience sector is pioneering innovations
The pace of medical innovation is accelerating around the world and right here in the Arizona bioscience sector. Biomedical innovators are pioneering in the fields of diagnostics, treatments, medical devices, and health technologies.Continue reading